
Bangladesh Drugmakers See Little Gain from US 100% Tariff Exemption
Specialty items like orphan drugs and plasma therapies qualify for zero duties under Section 232, but domestic manufacturers lack production capacity.
Tag
3 stories in this topic

Specialty items like orphan drugs and plasma therapies qualify for zero duties under Section 232, but domestic manufacturers lack production capacity.

Malaysia launched a pilot program on 1 September to reference Singapore assessments, aiming to eliminate duplicated reviews and accelerate pharmaceutical market entry across Southeast Asia.

Dr Neal Kassell of the Focused Ultrasound Foundation says global trials for pancreatic and brain cancers could yield major results within three years.
Weekly Briefing
Monday, Wednesday and a Friday Weekly Wrap: the retail stories, numbers and moves that mattered across Asia. Nothing else, and you can unsubscribe in one click.
Read by retail operators, investors and brand teams across Asia.